Ribociclib plus Endocrine Therapy in Early Breast Cancer

Author:

Slamon Dennis1,Lipatov Oleg1,Nowecki Zbigniew1,McAndrew Nicholas1,Kukielka-Budny Bozena1,Stroyakovskiy Daniil1,Yardley Denise A.1,Huang Chiun-Sheng1,Fasching Peter A.1,Crown John1,Bardia Aditya1,Chia Stephen1,Im Seock-Ah1,Ruiz-Borrego Manuel1,Loi Sherene1,Xu Binghe1,Hurvitz Sara1,Barrios Carlos1,Untch Michael1,Moroose Rebecca1,Visco Frances1,Afenjar Karen1,Fresco Rodrigo1,Severin Irene1,Ji Yan1,Ghaznawi Farhat1,Li Zheng1,Zarate Juan P.1,Chakravartty Arunava1,Taran Tetiana1,Hortobagyi Gabriel1ORCID

Affiliation:

1. From the David Geffen School of Medicine at the University of California, Los Angeles (D. Slamon, N.M.); Republican Clinical Oncology Dispensary, Ufa (O.L.), and Moscow City Oncology Hospital No. 62, Moscow (D. Stroyakovskiy) — both in Russia; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw (Z.N.), and Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli, Lublin (B.K.-B.) — both in Poland; the Sarah Cannon Research Institute at Tennessee Oncology, Nashville (D.A.Y.); the...

Funder

Novartis Pharmaceuticals Corporation

Publisher

Massachusetts Medical Society

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3